Detalhe da pesquisa
1.
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.
Lancet
; 388(10044): 565-75, 2016 Aug 06.
Artigo
Inglês
| MEDLINE | ID: mdl-27313086
2.
Should routine risk reduction procedures for the prevention and control of pandemics become a standard in all oncological outpatient clinics? The prospective COVID-19 cohort study: protect-CoV.
Med Oncol
; 39(6): 104, 2022 Apr 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35397689
3.
Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studiengruppe Hämatologie und Onkologie and the German Low-Grade Lymphoma Study Group.
Hemasphere
; 5(7): e600, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-34179697
4.
Nine months to progression using fourth-line liposomally encapsulated paclitaxel against hepatocellular carcinoma.
Chemotherapy
; 54(4): 309-14, 2008.
Artigo
Inglês
| MEDLINE | ID: mdl-18701819
5.
Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety.
J Clin Oncol
; 36(23): 2395-2404, 2018 08 10.
Artigo
Inglês
| MEDLINE | ID: mdl-29856692
6.
Panitumumab can safely and effectively be substituted for cetuximab in the treatment of BRAF V600Emut metastatic colorectal cancer (mCRC) - A case series.
Eur J Cancer
; 174: 37-39, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35970034
7.
Treatment strategies in follicular lymphomas: current status and future perspectives.
J Clin Oncol
; 23(26): 6394-9, 2005 Sep 10.
Artigo
Inglês
| MEDLINE | ID: mdl-16155025
8.
Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.
J Clin Oncol
; 34(12): 1386-94, 2016 Apr 20.
Artigo
Inglês
| MEDLINE | ID: mdl-26926679
9.
Open-label, randomized study of pegfilgrastim vs. daily filgrastim as an adjunct to chemotherapy in elderly patients with non-Hodgkin's lymphoma.
Leuk Lymphoma
; 44(9): 1503-8, 2003 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-14565651
10.
Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.
J Clin Oncol
; 32(13): 1338-46, 2014 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24687837
11.
Rituximab maintenance versus radioimmunotherapy consolidation in follicular lymphoma: which, when, and for whom?
Curr Hematol Malig Rep
; 6(4): 207-15, 2011 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-21909660
12.
Improvement of overall survival in advanced stage mantle cell lymphoma.
J Clin Oncol
; 27(4): 511-8, 2009 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-19075279
13.
Rituximab maintenance therapy in follicular lymphoma.
Curr Hematol Malig Rep
; 2(4): 213-8, 2007 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-20425372
14.
Primary effusion lymphoma (PEL) without effusion: a patient case report of a PEL solid variant.
J Clin Pathol
; 65(2): 189-90, 2012 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-22011447
15.
Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: Results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG).
Blood
; 108(13): 4003-8, 2006 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-16946304
16.
The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group.
Blood
; 104(10): 3064-71, 2004 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-15284112
17.
Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group.
Blood
; 104(9): 2667-74, 2004 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-15238420